Table 3 Response to immunotherapy stratified according to risk group (P=0.001)
CR, PR | SD | PD | ||||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Low risk, n=32 | 8 | 66.7 | 15 | 46.9 | 9 | 18.4 |
Medium, risk n=32 | 4 | 33.3 | 16 | 50.0 | 12 | 24.5 |
High risk, n=29 | 0 | 0 | 1 | 3.1 | 28 | 57.1 |
CR, PR | SD | PD | ||||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
Low risk, n=32 | 8 | 66.7 | 15 | 46.9 | 9 | 18.4 |
Medium, risk n=32 | 4 | 33.3 | 16 | 50.0 | 12 | 24.5 |
High risk, n=29 | 0 | 0 | 1 | 3.1 | 28 | 57.1 |